5.5 Plasma Cell Neoplasms & Monoclonal Gammopathies

Plasma Cell Neoplasms & Monoclonal Gammopathies

Plasma cell dyscrasias are listed by the ASCP BOC as a distinct lymphoid neoplasia sub-topic. They reach the hematology bench in three ways: as an unexplained rouleaux formation and a markedly elevated erythrocyte sedimentation rate on a routine smear, as a background staining abnormality that interferes with automated counts, and as marrow plasmacytosis on aspirate differential. The examination expects the diagnostic thresholds that separate a monoclonal gammopathy of undetermined significance from smoldering and symptomatic myeloma.

---

Plasma cell dyscrasias represent monoclonal proliferations of terminal B-lineage effector cells (plasma cells) that secrete a single, homogeneous monoclonal immunoglobulin or free light chain (M-protein / paraprotein).

                      SPEP / UPEP ELECTROPHORESIS PROFILE

 Albumin     α1     α2       β          γ (Gamma Region)
  ┌───┐                                   │
  │   │                                 ┌─┴─┐
  │   │                                 │ M │ ◄── Monoclonal M-Spike (IgG/IgA/IgM)
  │   │                                 │   │     (Sharp, narrow, dense band)
  │   │    ┌─┐    ┌───┐    ┌───┐        │   │
  │   │    │ │    │   │    │   │        │   │
──┴───┴────┴─┴────┴───┴────┴───┴────────┴───┴───────────────────────────────

A. Multiple Myeloma (MM)

Multiple Myeloma is a malignant neoplasm of terminally differentiated plasma cells accounting for ~10% of hematologic malignancies (median age ~69 years; more common in African Americans and males).

Diagnostic Criteria & CRAB Features

Diagnosis requires $\ge 10%$ clonal bone marrow plasma cells (or biopsy-proven plasmacytoma) PLUS at least one CRAB end-organ damage criterion (or a SLiM biomarker of malignancy: $\ge 60%$ marrow plasma cells, serum free light chain ratio $\ge 100$, or $>1$ focal lesion on MRI):

• C — Hypercalcemia: Serum calcium $>11.0\text{ mg/dL}$ (due to osteoclast-mediated bone resorption).
• R — Renal Insufficiency: Serum creatinine $>2.0\text{ mg/dL}$ or creatinine clearance $<40\text{ mL/min}$ (caused by myeloma cast nephropathy: excess monoclonal free light chains precipitate with Tamm-Horsfall mucoprotein in distal renal tubules).
• A — Anemia: Normocytic, normochromic anemia ($\text{Hb} < 10.0\text{ g/dL}$ or $>2.0\text{ g/dL}$ below normal) from bone marrow replacement and cytokine suppression.
• B — Bone Lesions: Multiple "punched-out" osteolytic bone lesions, severe osteopenia, or pathologic fractures on skeletal surveys, CT, or MRI (driven by plasma cell secretion of RANKL and DKK1, which activate osteoclasts and suppress osteoblasts).

                   MULTIPLE MYELOMA CRAB PATHOLOGY

 [C] Hypercalcemia      ──► Bone resorption from RANKL osteoclast activation
 [R] Renal Failure      ──► Light chain cast nephropathy (Bence Jones proteinuria)
 [A] Anemia             ──► Marrow replacement & cytokine-induced erythropoietin resistance
 [B] Bone Lytic Lesions ──► "Punched-out" skull/axial skeleton lesions & pathologic fractures

Peripheral Blood Smear & The Saline Replacement Technique

• Rouleaux Formation: High concentrations of cationic circulating paraproteins (M-protein) neutralize the negative sialic acid surface charge (zeta potential) of erythrocytes, causing red cells to aggregate and stack face-to-face like rolls of coins.
• Laboratory Differentiation (Rouleaux vs. Agglutination): True antigen-antibody cold agglutination (e.g., Cold Agglutinin Disease) forms irregular, clumped grape-like clusters, whereas rouleaux forms linear stacks. To differentiate:
  1. Centrifuge the sample and replace the plasma with an equal volume of 0.85% isotonic saline (Saline Replacement Technique).
  2. Result: Saline disperses rouleaux completely, whereas true antibody-mediated agglutination persists despite saline dilution.
• Plasma Cell Cytology: Malignant plasma cells display eccentric round nuclei, condensed "clock-face" or "cartwheel" chromatin, abundant deep royal-blue cytoplasm, and a prominent pale perinuclear halo (Golgi apparatus).
  • Mott Cells (Grape / Morular Cells): Plasma cells packed with clear, spherical cytoplasmic inclusions containing accumulated immunoglobulin (Russell bodies inside cytoplasm; Dutcher bodies inside the nucleus).
  • Flame Cells: Plasma cells with bright vermilion/pink-red margins, classically associated with IgA myeloma.

Laboratory Diagnostics & Immunophenotype

• Serum & Urine Protein Electrophoresis (SPEP / UPEP): Demonstrates a sharp, narrow, symmetric M-spike in the gamma or beta globulin region (monoclonal isotypes: IgG ~55%, IgA ~20%, Light chain only ~15–20%, IgD/IgE $<2%$).
• Bence Jones Protein: Monoclonal free kappa or lambda light chains in urine that precipitate between $56^\circ\text{C}$ and $60^\circ\text{C}$ and redissolve upon boiling at $100^\circ\text{C}$.
• Diagnostic Flow Cytometry: Neoplastic plasma cells are CD138+ (Syndecan-1), CD38+ (bright), CD56+ (aberrant NCAM expression), CD117+, with monoclonal cytoplasmic light chain restriction ($\kappa$ or $\lambda$). Malignant plasma cells are characteristically CD19 NEGATIVE and CD45 NEGATIVE (distinguishing them from normal reactive plasma cells, which are CD19+CD45+CD56-).

B. Monoclonal Gammopathy of Undetermined Significance (MGUS)

• Diagnostic Thresholds: Serum M-protein $<3.0\text{ g/dL}$, clonal bone marrow plasma cells $<10%$, and complete absence of CRAB end-organ damage or amyloidosis.
• Progression: Carries an obligatory lifelong risk of progression to overt Multiple Myeloma at a rate of approximately $1%$ per year.

C. Waldenström Macroglobulinemia (WM) / Lymphoplasmacytic Lymphoma

• Definition: Clonal neoplasm of small lymphocytes, plasmacytoid lymphocytes, and plasma cells in the bone marrow that secrete a monoclonal IgM paraprotein.
• Pathognomonic Genetics: Somatic $MYD88$ L265P mutation is present in $>90\text{--}95%$ of cases (causing continuous downstream TLR-IRAK-NF-$\kappa$B signaling).
• Clinical Hallmark: Hyperviscosity Syndrome caused by the large, pentameric structure of IgM ($970\text{ kDa}$). Manifests with visual blurring, "sausage-link" retinal vein dilation, retinal hemorrhages, epistaxis, dizziness, and headaches. Unlike myeloma, lytic bone lesions and hypercalcemia are absent.

---